Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Net Income: 2009-2024

Historic Net Income for Assembly Biosciences (ASMB) over the last 14 years, with Dec 2024 value amounting to -$40.2 million.

  • Assembly Biosciences' Net Income rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.2 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
  • Assembly Biosciences' Net Income amounted to -$40.2 million in FY2024, which was up 34.38% from -$61.2 million recorded in FY2023.
  • Over the past 5 years, Assembly Biosciences' Net Income peaked at -$40.2 million during FY2024, and registered a low of -$129.9 million during FY2021.
  • Moreover, its 3-year median value for Net Income was -$61.2 million (2023), whereas its average is -$64.8 million.
  • Its Net Income has fluctuated over the past 5 years, first skyrocketed by 36.34% in 2020, then tumbled by 108.93% in 2021.
  • Assembly Biosciences' Net Income (Yearly) stood at -$62.2 million in 2020, then crashed by 108.93% to -$129.9 million in 2021, then grew by 28.31% to -$93.1 million in 2022, then soared by 34.23% to -$61.2 million in 2023, then skyrocketed by 34.38% to -$40.2 million in 2024.